BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23477808)

  • 1. Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample.
    Franco L; Williams FM; Trofimov S; Surdulescu G; Spector T; Livshits G
    Metabolism; 2013 Aug; 62(8):1081-7. PubMed ID: 23477808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Supplementation with Grape Pomace and Omija Fruit Ethanol Extracts Dose-Dependently Improves Body Composition, Plasma Lipid Profiles, Inflammatory Status, and Antioxidant Capacity in Overweight and Obese Subjects.
    Han HJ; Jung UJ; Kim HJ; Cho SJ; Kim AH; Han Y; Choi MS
    J Med Food; 2016 Feb; 19(2):170-80. PubMed ID: 26796927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
    Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.
    Kaysen GA; Kotanko P; Zhu F; Sarkar SR; Heymsfield SB; Kuhlmann MK; Dwyer T; Usvyat L; Havel P; Levin NW
    J Ren Nutr; 2009 Sep; 19(5):357-64. PubMed ID: 19596588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
    Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.
    Barkas F; Elisaf M; Liberopoulos E; Liontos A; Rizos EC
    Atherosclerosis; 2016 Apr; 247():58-63. PubMed ID: 26868509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
    Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P
    Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
    Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
    Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
    Sattar N; Williams K; Sniderman AD; D'Agostino R; Haffner SM
    Circulation; 2004 Oct; 110(17):2687-93. PubMed ID: 15492304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins A-I and B in Kuwaiti children.
    Moussa MA; Shaltout AA; Nkansa-Dwamena D; Mourad M
    Ann Nutr Metab; 1998; 42(4):202-10. PubMed ID: 9745106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.